Table 2 Association between IL17A expression and clinicopathologic characteristics using logistic regression
From: Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer
Characteristics | Total (N) | Odds ratio in IL17A expression | P value |
|---|---|---|---|
T stage (T3 and T4 vs. T1 and T2) | 487 | 0.572 (0.393–0.830) | 0.003*** |
Age (> 60 vs. <= 60) | 501 | 1.241 (0.874–1.764) | 0.228 |
Gender (male vs. female) | 502 | 0.922 (0.620–1.369) | 0.687 |
N stage (N1 and N2 and N3 vs. N0) | 480 | 0.860 (0.601–1.231) | 0.410 |
M stage (M1 vs. M0) | 477 | 0.644 (0.084–3.923) | 0.632 |
Clinical stage (III and IV vs. I and II) | 488 | 0.715 (0.467–1.088) | 0.119 |
Histologic grade (G3 and G4 vs. G1 and G2) | 483 | 1.028 (0.681–1.553) | 0.896 |
Lymph vascular invasion (yes vs. no) | 341 | 0.558 (0.353–0.876) | 0.012* |
Lymph node neck dissection (yes vs. no) | 499 | 0.725 (0.456–1.145) | 0.170 |